Skip to main content
. 2018 Nov 23;30(3):e32. doi: 10.3802/jgo.2019.30.e32

Fig. 1. Schema of workflow for ctDNA analysis (A) and diagram showing the flow of patients in this study (B).

Fig. 1

CA 125, cancer antigen 125; ctDNA, circulating tumor DNA; HGSOC, high-grade serous ovarian cancer; PCR, polymerase chain reaction; TP53mut, TP53 mutation.